Creating non-hallucinogenic analogs of LSD and psilocybin to treat mental illnesses

Is COVID-19 on airplane air filters?
28 January 2022
New blood test combined with image-based prostate cancer screening reduces harm and costs
28 January 2022

Creating non-hallucinogenic analogs of LSD and psilocybin to treat mental illnesses

A combined team of researchers from the Shanghai Institute of Biochemistry and Cell Biology and ShanghaiTech University’s, iHuman Institute has created non-hallucinogenic analogs of LSD and psilocybin for possible treatment of mental illnesses. In their paper published in the journal Science, the group describe the analogs they created and how they performed in mice.

Comments are closed.